T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescripti

LifeMD remains a Buy despite disappointing Q2 2026 results, with revenue and EBITDA guidance revised

DALLAS, Sept. 15, 2026 /PRNewswire/ -- Through an exclusive collaboration with LifeMD, eligible AT&T

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the

B. Riley Securities analyst William Woods maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers th

LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript

LifeMD NASDAQ: LFMD reported second-quarter revenue of $47.3 million, within its prior guidance rang

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Est

UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue

LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $220.000 million-$230.000 million to $205.500

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.16) per share which missed the analyst consens

LifeMD (NASDAQ: LFMD - Get Free Report) and Ryman Healthcare (OTCMKTS:RYHTY - Get Free Report) are b

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtu

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and specialty care today ann

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establis

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtu

LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Esti

LifeMD (NASDAQ:LFMD) affirms FY2026 sales outlook from $220.000 million-$230.000 million to $220.000

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.20) per share which beat the analyst consensus

First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in l

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virt

Hims & Hers stock falls as Amazon launches a weight loss program with integrated care, pricing o

LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend i

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced tha

Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the

https://www.sec.gov/Archives/edgar/data/948320/0001493152-26-011228-index.html

LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the

Wall Street analysts upgraded PennyMac, LifeMD, Upstart, Circle Internet, and Rocket Companies. See

Mizuho analyst Steven Valiquette upgrades LifeMD (NASDAQ:LFMD) from Neutral to Outperform and rai

Freedom Capital Markets analyst Ilya Zubkov maintains LifeMD (NASDAQ:LFMD) with a Buy and raises

Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.04) per share which beat the analyst consensus

Novo Nordisk launches Wegovy weight loss pill in the US, showing up to 17% weight loss, with prices

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the

Keybanc analyst Steve Dechert maintains LifeMD (NASDAQ:LFMD) with a Overweight and lowers the pr

Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Neutral and lowers the pri